<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0412041</journal-id>
<journal-id journal-id-type="pubmed-jr-id">133</journal-id>
<journal-id journal-id-type="nlm-ta">Acta Neuropathol</journal-id>
<journal-id journal-id-type="iso-abbrev">Acta Neuropathol.</journal-id>
<journal-title-group>
<journal-title>Acta neuropathologica</journal-title>
</journal-title-group>
<issn pub-type="ppub">0001-6322</issn>
<issn pub-type="epub">1432-0533</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26961251</article-id>
<article-id pub-id-type="pmc">6774634</article-id>
<article-id pub-id-type="doi">10.1007/s00401-016-1553-1</article-id>
<article-id pub-id-type="manuscript">NIHMS906624</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of glial specific Kir4.1 in normal and pathological states
of the CNS</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nwaobi</surname>
<given-names>Sinifunanya E</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cuddapah</surname>
<given-names>Vishnu A</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Patterson</surname>
<given-names>Kelsey C</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Randolph</surname>
<given-names>Anita C</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olsen</surname>
<given-names>Michelle L</given-names>
</name>
</contrib>
<aff id="A1">Department of Cell, Developmental and Integrative Biology, and Center
for Glial Biology in Medicine, University of Alabama at Birmingham, Birmingham,
AL 35294</aff>
</contrib-group>
<author-notes>
<corresp id="CR1">Corresponding Author: Michelle Olsen, PhD, Department of Cell,
Developmental and Integrative Biology, University of Alabama at Birmingham, 1918
University Blvd, Birmingham, AL 35294, <email>molsen@uab.edu</email>, Phone:
205.975.2715</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P42">The authors declare no competing financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>12</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>02</day>
<month>10</month>
<year>2019</year>
</pub-date>
<volume>132</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>21</lpage>
<!--elocation-id from pubmed: 10.1007/s00401-016-1553-1-->
<abstract id="ABS1">
<p id="P1">Kir4.1 is an inwardly rectifying K<sup>+</sup> channel expressed
exclusively in glial cells in the central nervous system. In glia, Kir4.1 is
implicated in several functions which include extracellular K<sup>+</sup>
homeostasis, maintenance of astrocyte resting membrane potential, cell volume
regulation and facilitation of glutamate uptake. Knockout of Kir4.1 in rodent
models leads to severe neurological deficits, including ataxia, seizures,
sensorineural deafness, and early postnatal death. Accumulating evidence
indicates that Kir4.1 plays an integral role in the central nervous system,
prompting many laboratories to study the potential role that Kir4.1 plays in
human disease. In this article, we review the growing evidence implicating
Kir4.1 in a wide array of neurological disease. Recent literature suggests
Kir4.1 dysfunction facilitates neuronal hyperexcitability and may contribute to
epilepsy. Genetic screens demonstrate that mutations of <italic>KCNJ10</italic>,
the gene encoding Kir4.1, causes SeSAME/EAST syndrome, which is characterized by
early onset seizures, compromised verbal and motor skills, profound cognitive
deficits, and salt wasting. <italic>KCNJ10</italic> has also been linked to
developmental disorders including autism. Cerebral trauma, ischemia, and
inflammation are all associated with decreased astrocytic Kir4.1 current
amplitude and astrocytic dysfunction. Additionally, neurodegenerative diseases
such as Alzheimer’s disease and amyotrophic lateral sclerosis demonstrate
loss of Kir4.1. This is particularly exciting in the context of
Huntington’s disease, another neurodegenerative disease in which
restoration of Kir4.1 ameliorated motor deficits, decreased medium spiny neuron
hyperexcitability, and extended survival in mouse models. Understanding the
expression and regulation of Kir4.1 will be critical in determining if this
channel can be exploited for therapeutic benefit.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>